Literature DB >> 30391676

Effects of oxygen challenging to tissue redox and pO2 status.

Ken-Ichiro Matsumoto1, James B Mitchell2, Murali C Krishna2.   

Abstract

Nitroxide free radicals can serve as redox-sensitive MRI contrast agents useful to image the redox status of tissue of interest. In this study, the effect of oxygen content in the inspired gas on the kinetics of metabolism of three nitroxides has been evaluated in the muscle and tumor in mice. SCC tumors (approximate size of 1.0 cm3) on the right hind leg of female C3H/Hen MTV- mice were prepared. Three nitroxides, 3-carboxy-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CxP), 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CmP), and 4-hydroxy-tetramethylpiperidine-N-oxyl (TEMPOL), having different lipophilicities were compared using MR redox imaging. T1-mapping of the tissues was obtained using a multi-slice multi-echo (MSME) sequence with several TRs. The three nitroxides showed differences in accumulation and metabolism/clearance in muscle and tumor. The cell impermeable nitroxide CxP displayed kinetic patterns of slow enhancement followed by a slow decline typical of clearance rather than metabolism. The cell permeable CmP on the other hand showed a relatively faster uptake and metabolism with a modestly higher rate of metabolism in the tumor than muscle. The TEMPOL on the other hand displayed a rapid uptake and reduction with a trend of significantly rapid decay rate in tumor tissue, while slightly higher maximum signal intensity and slower decay rate was observed in normal muscle. The reduction rate of TEMPOL in the tumor was significantly enhanced when the breathing gas had 100%-oxygen while it was not significantly different in the muscle. EPR oximetry studies monitoring the oxygen dependent linewidth of TEMPOL showed that the pO2 in the healthy tissue during carbogen breathing significantly increased normal tissue pO2 compared to air breathing whereas breathing 100%-oxygen made normal tissue slight hypoxic. Since TEMPOL is a radioprotector, our studies show that a combination of 100%-oxygen breathing and TEMPOL has a potential to enhance radioprotective effects to normal tissue.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MR redox imaging; Nitroxide; Redox sensitive contrast agent; T(1)-relaxivity; Tumor oxygenation

Mesh:

Substances:

Year:  2018        PMID: 30391676      PMCID: PMC8202967          DOI: 10.1016/j.freeradbiomed.2018.10.454

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  35 in total

1.  MR assessment of changes of tumor in response to hyperbaric oxygen treatment.

Authors:  Ken-ichiro Matsumoto; Marcelino Bernardo; Sankaran Subramanian; Peter Choyke; James B Mitchell; Murali C Krishna; Martin J Lizak
Journal:  Magn Reson Med       Date:  2006-08       Impact factor: 4.668

2.  Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents.

Authors:  Fuminori Hyodo; Ken-Ichiro Matsumoto; Atsuko Matsumoto; James B Mitchell; Murali C Krishna
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

3.  Concentration dependence of nitroxyl spin probes in liposomal solution: electron spin resonance and overhauser-enhanced magnetic resonance studies.

Authors:  V Meenakumari; Hideo Utsumi; A Jawahar; A Milton Franklin Benial
Journal:  J Liposome Res       Date:  2016-12-21       Impact factor: 3.648

4.  Organ specific mapping of in vivo redox state in control and cigarette smoke-exposed mice using EPR/NMR co-imaging.

Authors:  George L Caia; Olga V Efimova; Murugesan Velayutham; Mohamed A El-Mahdy; Tamer M Abdelghany; Eric Kesselring; Sergey Petryakov; Ziqi Sun; Alexandre Samouilov; Jay L Zweier
Journal:  J Magn Reson       Date:  2011-11-07       Impact factor: 2.229

5.  Intracellular hypoxia of tumor tissue estimated by noninvasive electron paramagnetic resonance oximetry technique using paramagnetic probes.

Authors:  Atsuko Matsumoto; Ken-ichiro Matsumoto; Shingo Matsumoto; Fuminori Hyodo; Anastasia L Sowers; Janusz W Koscielniak; Nallathamby Devasahayam; Sankaran Subramanian; James B Mitchell; Murali C Krishna
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

6.  In vivo L-band ESR and quantitative pharmacokinetic analysis of stable spin probes in rats and mice.

Authors:  N Nishino; H Yasui; H Sakurai
Journal:  Free Radic Res       Date:  1999-07

7.  Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging.

Authors:  Ana P Cotrim; Fuminori Hyodo; Ken-Ichiro Matsumoto; Anastasia L Sowers; John A Cook; Bruce J Baum; Murali C Krishna; James B Mitchell
Journal:  Clin Cancer Res       Date:  2007-08-15       Impact factor: 12.531

Review 8.  Potential use of nitroxides in radiation oncology.

Authors:  S M Hahn; C M Krishna; A Samuni; W DeGraff; D O Cuscela; P Johnstone; J B Mitchell
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

Review 9.  Amifostine: the first selective-target and broad-spectrum radioprotector.

Authors:  John R Kouvaris; Vassilis E Kouloulias; Lampros J Vlahos
Journal:  Oncologist       Date:  2007-06

10.  Noninvasive mapping of the redox status of dimethylnitrosamine-induced hepatic fibrosis using in vivo dynamic nuclear polarization-magnetic resonance imaging.

Authors:  Takahito Kawano; Masaharu Murata; Fuminori Hyodo; Hinako Eto; Nuttavut Kosem; Ryosuke Nakata; Nobuhito Hamano; Jing Shu Piao; Sayoko Narahara; Tomohiko Akahoshi; Makoto Hashizume
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.